General Biotechnology

How to use patent expiry intelligence to reach biosimilar manufacturers at the moment their equipment decisions are live — not after they have already been made

Biosimilar timelines aren’t linear—so why are outreach strategies?
If you’re trying to reach biosimilar manufacturers, you’re probably doing it the hard way: waiting until a patent expiry date is “close enough,” then assuming the commercial and technic…

How to use patent expiry intelligence to reach biosimilar manufacturers at the moment their equipment decisions are live — not after they have already been made Read Post »

Biotechblog
Scroll to Top